LeonaBio, Inc. (LONA)
NASDAQ: LONA · Real-Time Price · USD
11.35
+1.33 (13.27%)
At close: Apr 2, 2026, 4:00 PM EDT
11.14
-0.21 (-1.85%)
After-hours: Apr 2, 2026, 6:56 PM EDT
LeonaBio Market Cap
LeonaBio has a market cap or net worth of $105.96 million as of April 2, 2026. Its market cap has increased by 683.50% in one year.
Market Cap
105.96M
Enterprise Value
19.37M
1-Year Change
683.50%
Ranking
Category
Stock Price
$11.35
Market Cap Chart
Since September 18, 2020, LeonaBio's market cap has decreased from $527.32M to $105.96M, a decrease of -79.91%. That is a compound annual growth rate of -25.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 105.96M | 254.92% |
| Dec 31, 2025 | 29.86M | 31.60% |
| Dec 31, 2024 | 22.69M | -75.47% |
| Dec 29, 2023 | 92.47M | -22.89% |
| Dec 30, 2022 | 119.92M | -75.36% |
| Dec 31, 2021 | 486.68M | -56.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AN2 Therapeutics | 117.53M |
| Genelux | 114.04M |
| ProMIS Neurosciences | 112.19M |
| Biomea Fusion | 111.34M |
| Cardiff Oncology | 108.02M |
| Oncolytics Biotech | 103.33M |
| Aldeyra Therapeutics | 99.90M |
| Turn Therapeutics | 98.64M |